Liraglutide Promotes Natriuresis but Does Not Increase Circulating Levels of Atrial Natriuretic Peptide in Hypertensive Subjects With Type 2 Diabetes - Lovshin, Julie A.; Barnie, Annette; DeAlmeida, Ariana; Logan, Alexander; Zinman, Bernard; Drucker, Daniel J. (Diabetes care, 2015)
Keywords: Adult; Aged; Atrial Natriuretic Factor - blood; Blood pressure; Blood Pressure - drug effects; Body Weight; Cross-Over Studies; Diabetes; Diabetes Mellitus, Type 2 - drug therapy; Double-Blind Method; Drug use; Endpoint Determination; Female; Glucagon-Like Peptide 1 - administration & dosage; Glucagon-Like Peptide 1 - analogs & derivatives; Glucagon-Like Peptide-1 Receptor; Heart rate; Heart Rate - drug effects; Humans; Hypertension; Hypertension - drug therapy; Liraglutide; Male; Middle Aged; Natriuresis - drug effects; Natriuretic Peptide, Brain - blood; Obesity; Peptide Fragments - blood; Peptides; Physiology; Receptors, Glucagon - agonists; Receptors, Glucagon - blood; Sodium - urine